Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges.

[1]  G. Andriole,et al.  Novel non-MRI imaging techniques for primary diagnosis of prostate cancer: micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, and PSMA PET/CT. , 2023, Prostate cancer and prostatic diseases.

[2]  H. Woo,et al.  Functional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysis. , 2023, Prostate cancer and prostatic diseases.

[3]  M. Cooperberg,et al.  Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022. , 2023, JAMA.

[4]  J. D. de Bono,et al.  A Transgender Patient with Prostate Cancer: Lessons Learnt. , 2023, European urology.

[5]  M. Emberton,et al.  Prostatic high-resolution micro-ultrasound: an attractive step-forward in the management of prostate cancer patients , 2022, Prostate Cancer and Prostatic Diseases.

[6]  F. Crocetto,et al.  Micro-Ultrasound in the Diagnosis and Staging of Prostate and Bladder Cancer: A Comprehensive Review , 2022, Medicina.

[7]  M. Cooperberg,et al.  Prostate-Specific Antigen Screening in Transgender Patients. , 2022, European urology.

[8]  N. Kyprianou,et al.  Prostate cancer in transgender women: considerations for screening, diagnosis and management , 2022, British Journal of Cancer.

[9]  E. Hyams,et al.  The state of PSA counseling in male‐to‐female transgender patients in the U.S. , 2022, The Prostate.

[10]  P. Verze,et al.  Hyperbaric oxygen therapy as adjuvant treatment for surgical site infections after male‐to‐female gender affirmation surgery: A 10‐year experience , 2022, Andrology.

[11]  J. Meningaud,et al.  Prostate cancer awareness among transgender women after gender‐affirming surgery , 2022, The Prostate.

[12]  M. Emberton,et al.  The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging in Primary and Recurrent Prostate Cancer: A Systematic Review of the Literature. , 2021, European urology focus.

[13]  H. Ahmed,et al.  Prostate cancer in transgender women: what does a urologist need to know? , 2021, BJU international.

[14]  I. Ouzaid,et al.  Is it Worth Starting Sexual Rehabilitation Before Radical Prostatectomy? Results From a Systematic Review of the Literature , 2021, Frontiers in Surgery.

[15]  A. Jemal,et al.  Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States , 2021, Journal of the National Cancer Institute.

[16]  M. Irwig,et al.  Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review , 2021, Journal of General Internal Medicine.

[17]  Anurag K. Singh,et al.  Prostate Cancer Screening Patterns Among Sexual and Gender Minority Individuals. , 2020, European urology.

[18]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[19]  M. den Heijer,et al.  Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment , 2020, The Journal of clinical endocrinology and metabolism.

[20]  Mandi L. Pratt-Chapman,et al.  Provider Recommendations Are Associated with Cancer Screening of Transgender and Gender-Nonconforming People: A Cross-Sectional Urban Survey , 2020, Transgender health.

[21]  J. Motmans,et al.  Epidemiological considerations in transgender health: A systematic review with focus on higher quality data. , 2020, International journal of transgender health.

[22]  Richard J Lee,et al.  Prostate cancer in transgender women. , 2018, Urologic oncology.

[23]  A. Jemal,et al.  Frequency and distribution of primary site among gender minority cancer patients: An analysis of U.S. national surveillance data. , 2018, Cancer epidemiology.

[24]  Ariella R. Tabaac,et al.  Gender Identity Disparities in Cancer Screening Behaviors. , 2018, American journal of preventive medicine.

[25]  O. Franco,et al.  Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study , 2017, Systematic Reviews.

[26]  R. Autorino,et al.  Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges. , 2017, Urology.

[27]  T. Lash,et al.  Cohort study of cancer risk among insured transgender people. , 2017, Annals of epidemiology.

[28]  G. Prins,et al.  The Development of Prostate Adenocarcinoma in a Transgender Male to Female Patient: Could Estrogen Therapy Have Played a Role? , 2017, The Prostate.

[29]  S. Elzanaty,et al.  Association between Serum Testosterone and PSA Levels in Middle-Aged Healthy Men from the General Population , 2017, Current Urology.

[30]  M. Matrana,et al.  Metastatic Prostate Cancer 35 Years After Sex Reassignment Surgery. , 2016, Clinical genitourinary cancer.

[31]  L. Gooren,et al.  Prostate cancer incidence in orchidectomised male‐to‐female transsexual persons treated with oestrogens , 2014, Andrologia.

[32]  C. Chew‐Graham,et al.  PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews , 2014, BMC Health Services Research.

[33]  S. Prescott,et al.  Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[34]  I. Kaplan,et al.  Prostate cancer in a transgender woman 41 years after initiation of feminization. , 2006, JAMA.

[35]  D. Newling,et al.  Metastatic prostatic carcinoma in a male-to-female transsexual. , 1998, British journal of urology.